コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g responders (including patients with narrow QRS complexes).
2 outcomes in heart failure patients with wide QRS complex.
3 , characterized by additional notches in the QRS complex.
4 f the first two orthogonal components of the QRS complex.
5 on of different orthogonal components of the QRS complex.
6 d left ventricular (LV) function, and a wide QRS complex.
7 n chronic systolic heart failure with a wide QRS complex.
8 oms, a reduced ejection fraction, and a wide QRS complex.
9 tients with a low ejection fraction and wide QRS complex.
10 the cardiac mortality compared with a narrow QRS complex.
11 ll-cause mortality rate compared with narrow QRS complex.
12 al) from each of nine unknown samples of the QRS complex.
13 ctor of incident CHD events in men with wide QRS complex.
14 ine, having either normal conduction or wide QRS complex.
15 ctuates cyclically back and forth across the QRS complex.
16 n a fairly constant position relative to the QRS complex.
17 n may depolarize tissue after the end of the QRS complex.
18 n negative deflection until greater than the QRS complex.
19 lectrocardiogram in the presence of a narrow QRS complex.
20 nt with (in the opposite direction from) the QRS complex.
21 sk features including wide and low-amplitude QRS complexes.
22 ation pattern was computed from the recorded QRS complexes.
23 mice showed normal baseline heart rates and QRS complexes.
24 Association class 3.4 +/- 0.5) and a widened QRS complex (184 +/- 31 ms) underwent robotic LV lead pl
26 epressed ejection fraction (EF) and a narrow QRS complex, albeit in a small number of patients, and w
27 cles of mutant animals, including diminished QRS complex amplitude consistent with loss of electrical
28 n patients with heart failure (HF) with wide QRS complex and diminished left ventricular (LV) functio
30 s, to detect the abnormality in PR interval, QRS complex and QT interval the Coefficient Variation (C
32 ature contractions with an elongation of the QRS complex and the hearts were more susceptible to isop
33 e., the spatial electrical angle between the QRS complex and the T-wave; p = 0.0005), wider QRS compl
34 nds (ms) after the end of the last conducted QRS complex and then scanned decrementally through that
36 ndex, had elevated heart rate, had prolonged QRS complex, and had lower prevalence of history of prio
37 n a non-LBBB (left bundle branch block) wide QRS complex, and lower left ventricular ejection fractio
38 with a reduced ejection fraction, a widened QRS complex, and NYHA class II or III heart failure, the
39 CG localized features including PR interval, QRS complex, and QT interval from the continuous ECG wav
43 tion functional class I and II and with wide QRS complexes, carvedilol was associated with a 30% redu
44 ctionated late potentials (96+/-47 ms beyond QRS complex) clustering exclusively in the anterior aspe
48 D), high RVP burden >= 20%, and a wide paced QRS complex duration >= 150 ms were randomly assigned to
53 hat influenced model predictions (precordial QRS complexes for all outcomes; T waves for LV dysfuncti
57 he electrophysiological underpinnings of the QRS complex has become important not only to predict res
59 nts for association with ten measures of the QRS complex in 12 leads, using 405,732 electrocardiogram
61 ams revealed significant prolongation of the QRS complex in adult Cx43 -/+ mice (13.4+/-1.8 ms, n = 1
62 te the advantage of in-depth analysis of the QRS complex in conjunction with other cardiovascular phe
65 cessing method projects all ECG leads of the QRS complex into optimized three perpendicular dimension
68 sed by delayed ventricular contraction (wide QRS complex), is a common feature of cardiomyopathy and
71 In ICD patients with HF, a wide underlying QRS complex more than doubles the cardiac mortality comp
74 ct of ADS synchronized to normally conducted QRS complexes (NQRS) and to supraventricular complexes w
77 rface ECGs revealed that late notches in the QRS complexes of lateral leads were associated with CCB
81 t were significantly delayed with respect to QRS complex onset (3.7+/-0.7 ms in WT [n=6] and 6.5+/-0.
84 ed by difficulty in assessing: 1) changes in QRS complexes or P-waves that indicate fusion, and 2) th
85 ifocal ectopic ventricular beats with narrow QRS complexes, originating from various ectopic foci alo
86 ignificant with the duration of the filtered QRS complex (p < 0.001 for QRS duration, p < 0.01 for la
87 S complex and the T-wave; p = 0.0005), wider QRS complex (p = 0.004), longer QTrr (i.e., age- and gen
88 bserved an 80% reduction in amplitude of the QRS complex, profound systolic dysfunction, decreased co
93 resulted in a consistent prolongation of the QRS complex, showing up to 40% increase from baseline, e
94 2 groups were detected for the PR interval, QRS complex, ST-segment duration, T-wave duration, QTc,
95 ncordant with (in the same direction as) the QRS complex; ST-segment depression of 1 mm or more in le
96 tive of the atrioventricular block), widened QRS complexes (suggesting intraventricular block), and e
97 evidence of sinus bradycardia and fragmented QRS complex, supporting the critical role of Slc26a6 in
103 ntervals, PAWP was measured gated to the ECG QRS complex to calculate the QRS-gated DPD (diastolic pu
104 the electric delay from the beginning of the QRS complex to the local LV electrogram (QLV), was found
105 t of variation of the time interval from the QRS complex to the onset of expansion and to early diast
107 during normal sinus rhythm that reflects the QRS complex vector during prior periods of ventricular p
112 chrony also occurs in patients with a narrow QRS complex, which suggests the potential usefulness of
113 ported were transient arrhythmia, reversible QRS-complex widening, transient hypotension and mild non
116 VCD did not differ from patients with narrow QRS complexes with regard to occurrence of tachycardias.
117 class II-IV heart failure symptoms, and wide QRS complex, with established chemotherapy-induced cardi